- Substantially equivalent: Jul 22, 2024
- Review time: 145 days
- Recalls: 0
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFNAVOYCDS is intended to be used with patient data from already cleared patient monitoring devices which measure respiratory rate, systolic blood pressure, and Glasgow Coma Scale (GCS) in adult patients being monitored in a healthcare facility.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- SpassageQK230386 · Spass, Inc. · Jun 15, 2023
Other PLB Clearances
The newest 510(k)s for the same product code; their median review was 125 days; see every PLB device- Aitrics-VcK240756 · Aitrics Co., Ltd. · Jul 23, 2024
- SpassageQK230386 · Spass, Inc. · Jun 15, 2023
- T3 Platform softwareK213423 · Etiometry, Inc. · Jan 6, 2023
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Feb 28, 2024
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.2300
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files